Regulation of IL-10 secretion after phagocytosis of Mycobacterium tuberculosis by human monocytic cells

Cytokine

Volumn 12, Issue 5, 2000, Pages 483-486

  Shaw, Terry C ^a   Thomas, Lynette H ^a   Friedland, Jon S ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Interleukin 10; Monocyte; Signal transduction; Tuberculosis

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; INTERLEUKIN 10; INTERLEUKIN 8; LATEX; NEUTRALIZING ANTIBODY; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE INHIBITOR; ZYMOSAN;

ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DOWN REGULATION; HOST; HUMAN; HUMAN CELL; IMMUNE RESPONSE; KINETICS; MONOCYTE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN SYNTHESIS; TISSUE INJURY; TUBERCULOSIS;

EID: 0033937584     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.1999.0586     Document Type: Article

References (15)

1. Friedland, JS, 1997, Tuberculosis, Remick, DGFriedlands, JS, Cytokines in health and disease, Marcel Dekker, New York, 609, 622.
2. Lin Y, Zhang M, Hofman FM, Gong J, Barnes PF. Absence of a prominent Th2 cytokine response in human tuberculosis. Infect Immun. 64:1996;1351-1356.
3. Zhang M, Lin Y, Iyer DV, Gong J, Abrams JS, Barnes PF. T-cell cytokine responses in human infection with Mycobacterium tuberculosis. Infect Immun. 63:1995;3231-3234.
4. Silver RF, Li Q, Ellner JJ. Expression of virulence of Mycobacterium tuberculosis within human monocytes: virulence correlates with intracellular growth and induction of tumor necrosis factor alpha but not with evasion of lymphocyte-dependent monocyte effector functions. Infect Immun. 66:1998;1190-1199.
5. Vouret-Craviari V, Cenzuales S, Poli G, Mantovani A. Expression of Monocyte Chemotactic Protein-3 in human monocytes exposed to the mycobacterial cell wall component lipoarabinomannan. Cytokine. 9:1997;992-998.
6. Meisel C, Vogt K, Randow F, Liebental C, Volk H-D. Differential regulation of monocytic tumor necrosis factor-α and interleukin-10 expression. Eur J Immunol. 26:1996;1580-1586.
7. Krakauer T. Evidence for Protein Kinase C pathway in the response of human peripheral blood mononuclear cells to cholera toxin. Cell Immunol. 172:1996;224-228.
8. Friedland JS, Remick DG, Shattock R, Griffin GE. Secretion of Interleukin-8 following phagocytosis of Mycobacterium tuberculosis by human monocyte cell lines. Eur J Immunol. 22:1992;1373-1378.
9. Verbon A, Juffermans N, van Deventer SJH, Speelman P, van Duetekom H, van der Poll T. Serum concentrations of cytokines in patients with active tuberculosis (TB) and after treatment. Clin Exp Immunol. 115:1999;110-113.
10. Savedra R, Delude RL, Ingalls RR, Fenton MJ, Golenbock DT. Mycobacterial lipoarabinomannan recognition requires a receptor that shares components of the endotoxin signalling system. J Immunol. 157:1996;2549-2554.
11. Naito Y, Endo H, Arai K, Coffman RL, Arai N. Signal transduction in Th clones: target of differential modulation by PGE2 may reside downstream of the PKC-dependent pathway. Lancet. 8:1996;346-356.
12. Berbernou N, Esnault S, Shin H, Fekkar H, Guenounou M. Differential regulation of IFN-gamma, IL-10 and inducible nitric oxide synthase in human T cells by cyclic AMP-dependent signal transduction pathways. Immunology. 91:1997;361-368.
13. Appelberg R. Opposing effects of Interleukin-10 on mouse macrophage functions. Scand J Immunol. 41:1995;539-544.
14. Kobayashi E, Nakano H, Morimoto M, Tamaoki T. Calphostin C (UNC-1028C), a novel microbial compound, is a highly potent and specific inhibitor of protein kinase C. Biochem Biophys Res Comm. 159:1989;548-553.
15. Kase H, Iwahashi K, Nakanshi S, Matsuda Y, Yamada K, Takahashi M, Murakata C, Sato A, Kaneko M. K-252 compounds, novel and potent inhibitors of protein kinase C and cyclic nucleotide-dependent protein kinases. Biochem Biophys Res Comm. 142:1987;436-440.